Zhende Medical Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jianguo Lu

Algemeen directeur

CN¥1.6m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	8.3yrs
Eigendom CEO	1.5%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	2.3yrs

Recente managementupdates

Recent updates

Cautious Investors Not Rewarding Zhende Medical Co., Ltd.'s (SHSE:603301) Performance Completely

Oct 15

Does Zhende Medical (SHSE:603301) Have A Healthy Balance Sheet?

Apr 29

CEO

Jianguo Lu (54 yo)

8.3yrs

Tenure

CN¥1,605,300

Compensatie

Mr. Jianguo Lu is Chairman of the Board and General Manager of Zhende Medical Co., Ltd. from July 07, 2016.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jianguo Lu	Chairman of the Board & GM	8.3yrs	CN¥1.61m	1.47% CN¥ 90.6m
Zhendong Shen	Director & Deputy GM	no data	CN¥895.90k	0.22% CN¥ 13.8m
Dasheng Xu	Deputy GM & Director	no data	CN¥1.64m	0.098% CN¥ 6.0m
Jia Feng Wang	Director	no data	CN¥150.00k	0.00019% CN¥ 11.7k
Sheng Xiao Li	Independent Director	2.3yrs	CN¥150.00k	geen gegevens
Xiantao Zhang	Director	no data	CN¥696.90k	0.033% CN¥ 2.0m
Xiuyuan Hu	Chairman of the Supervisory Board	no data	geen gegevens	0.044% CN¥ 2.7m
Chafen Zhu	Independent Director	2.3yrs	CN¥150.00k	geen gegevens

2.3yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 603301 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.3 jaar), wat duidt op een nieuw bestuur.

Zhende Medical Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Less than half of directors are independent

No independent directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.55 (vs CN¥0.24 in 3Q 2023)

Cautious Investors Not Rewarding Zhende Medical Co., Ltd.'s (SHSE:603301) Performance Completely

Zhende Medical Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 23%

Second quarter 2024 earnings released: EPS: CN¥0.32 (vs CN¥0.34 in 2Q 2023)

Zhende Medical Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Does Zhende Medical (SHSE:603301) Have A Healthy Balance Sheet?

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

New major risk - Financial data availability

Zhende Medical Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment deteriorates as stock falls 18%

Now 23% undervalued after recent price drop

New major risk - Revenue and earnings growth

Zhende Medical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

New major risk - Financial data availability

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.71 in 2Q 2022)

Zhende Medical Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023

First quarter 2023 earnings released: EPS: CN¥0.55 (vs CN¥0.50 in 1Q 2022)

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.81 (vs CN¥0.46 in 3Q 2021)

Investor sentiment improved over the past week

Zhende Medical Co., Ltd. announced that it has received CNY 976.452074 million in funding from Zhejiang Zhende Holding Co., Ltd., Xuchang Zhende Landscaping Engineering Co., Ltd.

Second quarter 2022 earnings released: EPS: CN¥0.71 (vs CN¥0.54 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

No independent directors

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.46 (vs CN¥5.57 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.54 (vs CN¥4.63 in 2Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥1.12 (vs CN¥0.44 in 1Q 2020)

New 90-day low: CN¥56.86

New 90-day low: CN¥59.35

Third quarter earnings released

Zhende Medical Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020

Earnings released

New 90-day high - CN¥99.22

Zhende Medical Co., Ltd. to Report First Half, 2020 Results on Aug 18, 2020

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd